TSVC (TSV Capital) Research
Investment Thesis
TSVC (formerly TEEC Angel Fund) is a pioneering seed-stage venture capital firm founded in 2010 by Chinese immigrant entrepreneurs with deep operational experience at scale. The firm is dedicated to identifying and nurturing exceptional founders building transformative technologies in deeptech, healthtech, and the data economy. TSVC believes that the most defensible companies are built on hard technology and solve real problems at scale, and they leverage their Tsinghua network and operational expertise to support founders from seed through their critical early milestones.
Sector Focus
TSVC maintains a disciplined focus on three primary sectors:
Deep Technology:
- Semiconductors and advanced materials
- Robotics and automation
- Artificial intelligence and machine learning applications
- Physical AI and autonomous systems
- Advanced manufacturing and industrial tech
Healthtech & Life Sciences:
- Digital health and telehealth platforms
- Medical devices and biotech tools
- Healthcare AI and diagnostics
- Surgical robotics and med-tech innovation
Data Economy:
- Data infrastructure and analytics platforms
- Business intelligence and data visualization
- Real-time data processing systems
- Enterprise data solutions
The firm is particularly known for identifying defensible seed-stage opportunities in hard tech spaces where barriers to entry are high and technical talent is scarce.
Stage Focus and Check Size
TSVC is exclusively a seed-stage investor with deep expertise in pre-seed to Series A companies:
- Pre-Seed: $250K-$500K for prototype validation and team formation
- Seed: $500K-$3M for companies with product-market signals and early customers
- Occasional Series A: Selective follow-on investments in exceptional portfolio companies
Their typical check size ranges from $500,000 to $3,000,000, with a strong preference for seed-stage rounds where they can take meaningful board seats and provide operational support.
Lead vs Follow Tendency
TSVC has a both tendency - they frequently lead seed rounds (especially for companies in their thesis areas) but are also comfortable following strong lead investors. Their long track record and deep domain expertise allow them to either lead or co-invest strategically. In seed rounds where they have strong conviction, they prefer to lead or co-lead to establish meaningful ownership and board representation.
Recent Activity & Fund Status
TSVC is actively deploying from their current fund with continued momentum in 2025:
- Fund Status: Actively deploying, regularly announcing new investments
- 2025 Notable Investments: d-Matrix (became a unicorn in 2025), continued investments in physical AI and robotics
- Investment Pace: ~4 new investments in the last 12 months (as of Feb 2026)
- Latest Activity: December 2025 - January 2026
The firm maintains a disciplined approach with approximately 150-160 portfolio companies, demonstrating selective investing rather than a high-volume strategy.
Portfolio Highlights & Track Record
TSVC has an exceptional track record with significant exit success:
Unicorns (11 from seed):
- Zoom (IPO 2019, $16B+ market cap)
- Ginkgo BioWorks (IPO 2021, biotech engineering)
- Carta (valuation $7.5B+, fintech)
- Quanergy (LiDAR/autonomous vehicles)
- d-Matrix (AI inference, unicorn 2025)
- Wealthsimple (fintech)
- Zum (student transportation, $600M+ valuation)
- And 4 additional unicorns
IPOs: 5 public companies including Zoom, Ginkgo BioWorks, and Carta
Centaurs ($100M+ valuations): Exa Labs, Ridge Security, Petal Surgical, Bot Orange, and others
Acquisitions: 36+ successful exits including strategic acquisitions across tech sectors
Active Notable Companies:
- DeepMotion (AI motion synthesis, robotics)
- Various portfolio companies in physical AI, deeptech infrastructure, and healthtech
The firm's portfolio has generated $5B+ in total capital raised by portfolio companies, demonstrating exceptional capital efficiency and ability to identify breakout founders early.
Team & Leadership
Founding Partners:
- Eugene Zhang: Founding Partner, deep experience in deeptech and Chinese tech ecosystem
- Chun Xia: Founding Partner, operational expertise and network
General Partners:
- Charles Shao: VP of Easyway Inc., founding member of Netscreen and EPIN Tech, Tsinghua alumni with background in high-speed rail and transportation technology
- Spencer Greene: Former Head of M&A at Juniper Networks, led Design for Exit program, expertise in scaling and exits
Partners:
- Lisheng Wang: Partner, deep tech and infrastructure expertise
- Jiayan Liu: Partner
The team combines deep operational experience (Cisco, Juniper Networks), successful founder backgrounds, and strong connections to the Tsinghua University network in China, creating a unique advantage in identifying and supporting technical founders.
Geographic Focus
- Primary: Silicon Valley / SF Bay Area
- Secondary: United States broadly (East Coast, West Coast focus)
- International: Selective investments in China through Tsinghua network and partnerships
- Headquarters: Los Altos, California
Decision Process & Timeline
Decision Process: Partnership model with collaborative diligence among General Partners. Spencer Greene and other GPs often lead investment theses in their specialized areas.
Decision Timeline: Typically 2-4 weeks for aligned investments, with faster decisions for exceptional opportunities that fit core thesis.
Board Representation: GPs regularly take board seats in portfolio companies, providing strategic guidance and operational support beyond capital.
Investment Preferences & Founder Profile
Founder Preferences:
- Technical founders with deep domain expertise (PhDs, industry veterans)
- First-time founders with exceptional credentials and problem discovery
- Teams that have worked together previously or have complementary skills
- Founders solving hard problems in defensible technology areas
- Chinese immigrant entrepreneurs or those with Tsinghua connections benefit from network access
Notable Achievements
- TSVC was the first institutional investor in Zoom (2011), leading their seed round
- Early investor in Ginkgo BioWorks, understanding synthetic biology's potential
- Deep expertise in identifying defensible seed companies - focus on technical moats and sustainable competitive advantages
- Strong track record in post-seed scaling - portfolio companies successfully raise follow-on capital at elevated valuations
- Leverages operational expertise to provide value-add beyond capital (M&A strategy, scaling operations, technical recruitment)
- Network extends to corporate relationships with major tech companies for partnerships and customer validation
Fund Details
Fund Status: Actively deploying current fund Fund Size: Historical funds have ranged up to $100M+ (exact current fund size not publicly disclosed) Years Active: Founded 2010, operating for 16 years Investment Approach: Selective seed-stage focus with deep engagement in portfolio company operations